[24] [25] Weight management medications (including GLP-1 receptor agonists and orlistat) should generally be deferred until after weaning, unless exceptional circumstances warrant earlier intervention with careful risk-benefit assessment by specialists
The leading antioxidant, ACG Glutathione, is the first GSH Intra-oral spray providing rapid absorption, unsurpassed anti-oxidation, and improved cellular function
However, human resource decision-makers in charge of employee health plans acknowledge GLP-1s as beneficial for controlling blood sugar, boosting weight loss, and improving blood pressure, but 38% percent cited cost as a potential barrier to providing coverage
However, there is limited research that backs such claims
International recommendations for the management of children (177) treated with KD have been composed